Dear Mr. Davis,
I am afraid that the publicity about RISUG has been premature and
overstated. I just returned from India wher I was informed by the
authorities that the clinical trials on RISUG had been stopped due to
failures and possible toxicity.
We at CONRAD are committed to developing new methods of contraception
and male methods are an importan focus in our preogram.
Henry L.Gabelnick, Ph.D.
1611 North Kent Street, Suite 806
Arlington, VA 22209 USA